A study from National Taiwan University Hospital has unveiled how metabolic dysfunction significantly influences the mortality risks of patients with chronic hepatitis B (CHB). The research, recently published in the Journal of Hepatology, analyzed data from over 8,000 CHB patients over a 15-year period, highlighting the crucial role of metabolic health in liver disease outcomes.